Sage Therapeutics' CFO to leave, drugmaker to lay off over 165 employees
Sage Therapeutics said on Thursday its finance chief will leave the company and the drugmaker plans to lay off more than 165 employees as part of a reorganization plan that aims to focus on the launch of its postpartum depression pill.
Sage Therapeutics to lay off one-third of workforce
After a year of disappointing drug trial results, Sage Therapeutics Inc. is slashing its headcount and shaking up its leadership team.
After Series Of Trial Setbacks, Sage Therapeutics To Lay Off One-Third Workforce
Sage Therapeutics announces reorganization, including layoffs and pipeline changes, to support the launch of Zurzuvae. Focus shifts to Huntington's Disease trial after setbacks in essential tremor and Alzheimer's treatments.
Sage Therapeutics to lay off more than 165 employees
Sage Therapeutics said on Thursday it will lay off more than 165 employees, or about 33% of the company's total workforce, as part of a reorganization plan. The drugmaker plans to prioritize the launch of postpartum depression treatment Zurzuvae,
Sage Therapeutics to lay off one-third staff under reorganization
Sage Therapeutics (NASDAQ:SAGE) announced a reorganization, including a workforce reduction of about 33%, to support the ongoing launch of ZURZUVAE for postpartum depression and to focus on pipeline development ahead of a clinical readout for dalzanemdor in Huntington’s Disease expected later this year.
Sage Therapeutics Stock Is Dropping. A Workforce Reduction Is Hitting R&D Hard.
The biopharmaceutical company says the reorganization is meant to strengthen its balance sheet and position it for long-term ...
GlobalData on MSN8h
Sage lays off 55% of R&D workforce and refocuses pipeline
Strategic restructuring will support the ongoing launch of the oral postpartum depression drug, Zurzuvae, and extend Sage’s ...
FierceBiotech18h
Sage lays off half of R&D team, shakes up C-suite again
Sage Therapeutics’ latest attempt to shrink its pipeline and workforce will see a third of the biotech’s employees heading ...
Sage Cuts One-Third of Workforce After Clinical Trial Setbacks
Sage Therapeutics Inc. is laying off more than 165 employees as the biotech company tries to conserve cash after multiple ...
Sage Steele calls out Obama for 'scolding' Black men for lack of enthusiasm for Kamala Harris: 'Back off!'
"The Sage Steele Show" host Sage Steele joined "America's Newsroom" to call out former President Obama's statements to Black ...
SAGE Therapeutics’ Strategic Reorganization and Cautious Hold Rating Amid Development Setbacks
Needham analyst Ami Fadia has reiterated their neutral stance on SAGE stock, giving a Hold rating on October 10. Ami Fadia’s rating is ...
BioPharma Dive13h
Sage to cut one-third of workforce, streamline drug pipeline
The restructuring, which follows clinical setbacks in Alzheimer’s, Parkinson’s and tremor, will also involve the departure of five senior executives.
Sage Therapeutics Cutting Workforce by 33%
Sage on Thursday said the moves will affect more than 165 employees, representing about 33% of the Cambridge, Mass., company's total workforce and roughly 55% of its research-and-development staff.
NOLA.com2d
Savor the salvias, especially colorful Mexican bush sage, before they're gone
Salvias are known for their showy flower spikes that rise above their foliage. While many salvias start blooming in spring, ...
Sage Potash Continues to Strengthen Team by Adding Corporate Finance Veteran as CFO and Retains Terrarock Industries for Plant Construction
CNW/ -, (TSXV: SAGE) (OTC: SGPTF) ("Sage" or the "Company") is pleased to announce that Rod Reum has been appointed Chief ...